PartnerRe | LinkedIn (original) (raw)
Info
At PartnerRe, we are a community of curious, intelligent industry experts, united by a drive to outperform. As an international reinsurer with a robust capital base, we are a market leader with a reputation of financial stability and strength, and a commitment to rebuilding businesses and communities after risk events around the world.
Branche
Versicherungswesen
Größe
1.001–5.000 Beschäftigte
Hauptsitz
Stadtkreis 5 Industriequartier, Zurich
Art
Privatunternehmen
Gegründet
1993
Spezialgebiete
PartnerRe is a top-ten reinsurer worldwide
Orte
- Primär
Hardstrasse 301
Stadtkreis 5 Industriequartier, Zurich 8005, CH
Wegbeschreibung - 90 Pitts Bay Road
Pembroke, HM08, BM
Wegbeschreibung - 200 First Stamford Place
Suite 400
Stamford, CT 06902, US
Wegbeschreibung - 32 Rue Guersant
Paris, 75017, FR
Wegbeschreibung - 3rd Floor, The Exchange, Georges Dock, IFSC
Dublin, 1, IE
Wegbeschreibung - 8 Temasek Boulevard
#13-01/02, Suntec Tower 3
Singapore, 038988, SG
Wegbeschreibung
- 3837 Sun Hung Kai Centre, 30 Harbour Road
Wanchai, HK
Wegbeschreibung - 95 Wellington Street West
12th Floor
Toronto, Ontario M5J 2N7, CA
Wegbeschreibung - 14819 Ballantyne Village Way
Charlotte, North Carolina 28277, US
Wegbeschreibung - 6900 Wedgwood Road North
Suite 120
Maple Grove, Minneapolis, MN 55311, US
Wegbeschreibung - No.1 East Chang An Avenue
Room 1211, Office Tower C1, Oriental Plaza
Dong Cheng District, Beijing 100738, CN
Wegbeschreibung - 701 Brickell Avenue
Suite 2500
Miami, FL 33131, US
Wegbeschreibung - Montes Urales 424, Planta Baja
Suite PBB-118
Ciudad de México, Col. Lomas de Chapultepec V Sección Del. Miguel Hidalgo 11000, MX
Wegbeschreibung - 1, Allée du Wacken
Strasbourg, 67978, FR
Wegbeschreibung - 6 Gracechurch Street
London, England EC3V 0AT, GB
Wegbeschreibung - 2-12-10 Nihonbashi Kayabacho
PMO EX Nihonbashi Kayabacho 3F
Tokyo, Chuo-ku 103-0025, JP
Wegbeschreibung
Beschäftigte von PartnerRe
Updates
-
56.131 Follower:innen
4 Tage Bearbeitet
The US Food and Drug Administration (FDA) recently approved AUCATZYL for the treatment of relapsed or refractory B-cell precursor Acute Lymphoblastic Leukemia (ALL), an aggressive cancer that previously had limited treatments available for patients who experienced a relapse of the disease. Our PULSE + Plus team of dedicated clinical consultants can answer any questions you have about this therapy and its implications. We are here to help you manage your risk and prohibit mark-ups on life enhancing treatments like these. Learn more: https://lnkd.in/edZdMFze #celltherapy -
56.131 Follower:innen
1 Woche
Klaus Paesler, CFA, Global Head of Business Development, PartnerRe Capital Management, recently led a roundtable on reinsurance-linked investments at the Switzerland Institutional Forum in Zurich. Focusing on this unique asset class, the discussion looked at how ILS continues to provide diversification and uncorrelated returns for investment portfolios.#YourCapitalPartner #InstitutionalInvesting #ILS -
56.131 Follower:innen
1 Woche -
56.131 Follower:innen
1 Woche
Identifying the cause of an exceedingly high claim often requires a trained eye. PartnerRe’s PULSE + Plus clinical consultants are highly skilled at uncovering billing inaccuracies, supporting clients in optimizing their financial outcomes. Learn More: https://lnkd.in/eYaqWUCt -
56.131 Follower:innen
2 Wochen
Check out the podcast Cillian T., Head of Underwriting Propositions and Products, Life and Health participated in on #RighttoBeForgotten. This is part of the Practical Podcast series, Season 9, Episode 8.
Protection adviser (Cura), trainer (Advice for Advisers), podcaster (The PPP)
4 Monate
There’s a new episode of The Practical Protection Podcast out! I was joined by Cillian Tierney (Global Head of Medical Underwriting Propositions and Products at PartnerRe) to discuss how insurers in the EU are responding to the Right to be Forgotten. This legislation requires insurers to give consumers the right to not disclose that they have had cancer when they apply for some protection insurances. The rules are different across countries, with differing timescales and product ranges involved. Cillian shares his experience of how RTBF has developed in the Irish insurance market. The key takeaways are: - The Right to be Forgotten is not currently legislated in the UK. - The process used by insurers to assess insurance applications for people that have been diagnosed with cancer. - Three case studies that show where the RTBF would and wouldn’t improve terms for someone that has experienced cancer. Warning: This is potentially an emotional topic. We talk about it purely from a technical basis, which might not be easy to hear. You’ll find this episode wherever you listen to your podcasts. Or listen directly at the link below.#PracticalProtectionPodcast #RightToBeForgotten #InsuranceProtectionExpert